170 related articles for article (PubMed ID: 22682496)
1. Adenosine receptor expression in rheumatoid synovium: a basis for methotrexate action.
Stamp LK; Hazlett J; Roberts RL; Frampton C; Highton J; Hessian PA
Arthritis Res Ther; 2012 Jun; 14(3):R138. PubMed ID: 22682496
[TBL] [Abstract][Full Text] [Related]
2. Baseline adenosine receptor mRNA expression in blood as predictor of response to methotrexate therapy in patients with rheumatoid arthritis.
Singh A; Misra R; Aggarwal A
Rheumatol Int; 2019 Aug; 39(8):1431-1438. PubMed ID: 31203399
[TBL] [Abstract][Full Text] [Related]
3. Analysis of association of ADORA
Grk M; Milic V; Dolzan V; Maksimovic N; Damnjanovic T; Pjevic MD; Pesic M; Novakovic I; Jekic B
Pharmacogenomics J; 2020 Dec; 20(6):784-791. PubMed ID: 32448869
[TBL] [Abstract][Full Text] [Related]
4. ADORA2A Polymorphisms Influence Methotrexate Adverse Events in Rheumatoid Arthritis.
Kobold N; Jenko B; Tomšič M; Dolžan V; Praprotnik S
Isr Med Assoc J; 2019 May; 21(5):333-338. PubMed ID: 31140226
[TBL] [Abstract][Full Text] [Related]
5. The impact of single nucleotide polymorphisms in ADORA2A and ADORA3 genes on the early response to methotrexate and presence of therapy side effects in children with juvenile idiopathic arthritis: Results of a preliminary study.
Roszkiewicz J; Michałek D; Ryk A; Swacha Z; Szmyd B; Smolewska E
Int J Rheum Dis; 2020 Nov; 23(11):1505-1513. PubMed ID: 32969158
[TBL] [Abstract][Full Text] [Related]
6. Expression of methotrexate transporters and metabolizing enzymes in rheumatoid synovial tissue.
Stamp LK; Hazlett J; Highton J; Hessian PA
J Rheumatol; 2013 Sep; 40(9):1519-22. PubMed ID: 23858048
[TBL] [Abstract][Full Text] [Related]
7. Expression of the genes facilitating methotrexate action within subcutaneous rheumatoid nodules.
Houlder EL; Millier MJ; Highton J; Gwynne-Jones D; Stamp LK; Hessian PA
Clin Exp Rheumatol; 2017; 35(6):943-947. PubMed ID: 28598776
[TBL] [Abstract][Full Text] [Related]
8. Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium.
Ducreux J; Durez P; Galant C; Nzeusseu Toukap A; Van den Eynde B; Houssiau FA; Lauwerys BR
Arthritis Rheumatol; 2014 Jan; 66(1):15-23. PubMed ID: 24449571
[TBL] [Abstract][Full Text] [Related]
9. Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium.
Bramlage CP; Kaps C; Ungethüm U; Bramlage P; Koziolek M; Wessels J; Krenn V; Pruss A; Müller GA; Strutz F; Burmester GR; Häupl T
Scand J Rheumatol; 2008; 37(6):401-9. PubMed ID: 18830904
[TBL] [Abstract][Full Text] [Related]
10. Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate.
Varani K; Massara A; Vincenzi F; Tosi A; Padovan M; Trotta F; Borea PA
Arthritis Rheum; 2009 Oct; 60(10):2880-91. PubMed ID: 19790066
[TBL] [Abstract][Full Text] [Related]
11. The influence of coffee intake and genetics on adenosine pathway in rheumatoid arthritis.
Soukup T; Hloch K; Doseděl M; Tebbens JD; Nekvindová J; Šembera Š; Veleta T; Pávek P; Barvík I
Pharmacogenomics; 2020 Jul; 21(11):735-749. PubMed ID: 32615857
[No Abstract] [Full Text] [Related]
12. Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A3 adenosine receptor expression.
Ochaion A; Bar-Yehuda S; Cohn S; Del Valle L; Perez-Liz G; Madi L; Barer F; Farbstein M; Fishman-Furman S; Reitblat T; Reitblat A; Amital H; Levi Y; Molad Y; Mader R; Tishler M; Langevitz P; Zabutti A; Fishman P
Arthritis Res Ther; 2006; 8(6):R169. PubMed ID: 17101059
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms within the adenosine receptor 2a gene are associated with adverse events in RA patients treated with MTX.
Hider SL; Thomson W; Mack LF; Armstrong DJ; Shadforth M; Bruce IN
Rheumatology (Oxford); 2008 Aug; 47(8):1156-9. PubMed ID: 18539621
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate impact on radiographic progression in biologic-treated rheumatoid arthritis under clinical remission: A case report on monozygotic Caucasian twins.
Soukup T; Nekvindova J; Dosedel M; Brtkova J; Toms J; Bastecka D; Bradna P; Vlcek J; Pavek P
Int J Immunopathol Pharmacol; 2016 Dec; 29(4):790-795. PubMed ID: 27770044
[TBL] [Abstract][Full Text] [Related]
15. Histological analysis of synovium by treatment of etanercept for rheumatoid arthritis.
Suzuki Y; Inoue K; Chiba J; Inoue Y; Kanbe K
Int J Rheum Dis; 2009 Apr; 12(1):7-13. PubMed ID: 20374310
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate upregulates circadian transcriptional factors PAR bZIP to induce apoptosis on rheumatoid arthritis synovial fibroblasts.
Suzuki K; Yoshida K; Ueha T; Kaneshiro K; Nakai A; Hashimoto N; Uchida K; Hashimoto T; Kawasaki Y; Shibanuma N; Nakagawa N; Sakai Y; Hashiramoto A
Arthritis Res Ther; 2018 Mar; 20(1):55. PubMed ID: 29566767
[TBL] [Abstract][Full Text] [Related]
17. Reduced folate carrier-1 80G>A polymorphism affects methotrexate treatment outcome in rheumatoid arthritis.
Drozdzik M; Rudas T; Pawlik A; Gornik W; Kurzawski M; Herczynska M
Pharmacogenomics J; 2007 Dec; 7(6):404-7. PubMed ID: 17325736
[TBL] [Abstract][Full Text] [Related]
18. CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis.
Gupta V; Katiyar S; Singh A; Misra R; Aggarwal A
Int J Rheum Dis; 2018 Aug; 21(8):1548-1556. PubMed ID: 30146748
[TBL] [Abstract][Full Text] [Related]
19. Membrane-Spanning Protein Genetic Polymorphisms Related to Methotrexate Therapeutic Outcomes in a Chinese Rheumatoid Arthritis Population.
Lv S; Fan H; Yang H; Huang J; Li J; Shu X; Zhang L; Xu Y; Li X; Zuo J; Lv C; Kong X; Xiao C
J Clin Pharmacol; 2019 Nov; 59(11):1471-1476. PubMed ID: 31099054
[TBL] [Abstract][Full Text] [Related]
20. Reduced folate carrier-1 80G > A gene polymorphism is not associated with methotrexate treatment response in South Indian Tamils with rheumatoid arthritis.
Muralidharan N; Mariaselvam CM; Mithun CB; Negi VS
Clin Rheumatol; 2016 Apr; 35(4):879-85. PubMed ID: 25771854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
